Aktiesnakken — Oktober 2010
-
tak for det solsen - det lyder meget lovende
-
mon ikke GSK sætter turbo på - når det nu viser sig at Ofa har effekt i autoimmun?
-
eller læser jeg fase II resultaterne forkert?
-
hø - nu mangler vi bare at markedet finder ud af det, rytter...
-
kommer vi først i firstline i bare en enkelte indikation, så sker der ting og sager. Skidtet har jo ingen bivirkninger
lidt radikal har man vel lov at være, tror den går op når us vågner
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind